Background and aims Resilience and recovery are of increasing importance in the field of alcohol dependence (AD).
INTRODUCTION

Imaging recovery and resilience
The toxic effects of alcohol are seen particularly in the brain, as demonstrated by several post-mortem and in-vivo neuroimaging studies in individuals with alcohol dependence (AD; e.g. [1] [2] [3] ). Structural changes are observed clearly in the brain, including atrophy of gray and white matter with sulcal widening and ventricular enlargement. In addition, chronic alcohol consumption is accompanied by neural adaptations within different neurotransmitter systems, such as the dopamine system (cf. reviews [4] [5] [6] [7] [8] [9] ). These neural and molecular changes have been shown further to be associated with dysfunctional brain functions underlying psychological and behavioral processes in AD [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] .
Once harmful alcohol use stops or is reduced, beneficial recovery processes can be observed regarding physical and mental health (see [20] ) and in the brain, using various neuroimaging techniques [21] [22] [23] [24] . One of the main questions for neuroimaging research in the field of addictive disorders is to characterize predictors of recovery and treatment outcome [25] . It is notable, however, that a clear standard definition of the term 'recovery ' is not yet generally established. In this review, we will focus on structural and functional changes within the brain associated with reduction of alcohol intake or abstinence in AD investigated by studies using neuroimaging techniques as identified by our literature search.
Another consideration is to what extent abnormalities in brain structure and function are caused by the toxic effects of alcohol, or whether some of these differences might have been pre-existing and putatively predispose some individuals to develop alcohol dependence while others seem to have a protective effect, i.e. confer resilience [26] . Resilience is defined traditionally as the ability to adapt to adverse/traumatic environments, thus resulting in healthy long-term psychological functioning and better developmental outcomes [27] [28] [29] . Resilience research also concentrates on high-risk groups, which do not develop the disorder of interest despite carrying risk genes and/or experiencing adverse environmental conditions. Studying those individuals already affected, however, adds a new perspective to the understanding of disease development, disease progression and future potential treatment strategies by focusing on neurobiological factors that promote a good treatment outcome despite adversities. Thus, studies using neuroimaging techniques may help to identify such resilience mechanisms regarding the structural and functional markers of neural patterns associated with attenuating further disease progression and/or relapse in AD [10, 11, 30, 31] . Such factors are not defined by the absence of vulnerability markers, but rather by compensatory changes in biological markers that distinguish individuals with good treatment outcome from those who relapse and healthy controls.
We therefore reviewed the available literature to answer the following questions: (1) why are some people less vulnerable in developing addictive disorders in comparison with others; (2) to what extent can recovery processes be observed; and (3) why do some individuals with alcohol dependence achieve and maintain abstinence better, i.e. are more resilient than those who relapse?
METHODS
Search strategy
We reviewed systematically the existing literature up to November 2017 using the PUBMED electronic database for the identification of neuroimaging studies investigating recovery and/or resilience in alcohol dependence or alcohol dependence in humans, respectively. We therefore used the following search terms: imaging, neuroimaging, addiction, dependence, alcohol*, substance use*, substance use disorder, recovery, resilience. Bibliographies of relevant papers were additionally screened for further relevant information.
Study selection
We included peer-reviewed original studies irrespective of when the study was conducted and excluded single case studies, reviews and meta-analyses. For the sake of parsimony, we further excluded neuroimaging studies using imaging techniques other than functional magnetic resonance imaging (fMRI), structural MRI, diffusion tensor imaging (DTI) or positron emission tomography (PET). Additional exclusion criteria were: not in English, substances other than alcohol, neuropsychological studies without neuroimaging.
Extraction and quality assessment
One reviewer (K.C.) screened abstracts of papers identified for potential relevance. Then, two reviewers (A.B. and K.C.) extracted study data independently and screened further the bibliographies of relevant papers. In the event of uncertainty or disagreement regarding criteria for eligibility between A.B. and K.C., selected papers and manuscript drafts were discussed further with the third and fourth reviewers (F.W.L. and A.H.). Decisions on study selection were documented by A.R.
RESULTS
Search results
The initial term search identified a total of 1066 papers, 175 of which were considered potentially relevant. Additionally, seven were identified through screening the reference lists of selected papers. Of those, 145 papers were excluded further, as described in Fig. 1 , according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) group [32] . Finally, 35 studies were included in our review (for details, please see Table 1 and Supporting information, Appendix S1).
Resilience and recovery markers detected by fMRI
We found nine relevant fMRI studies [10] [11] [12] [33] [34] [35] [36] [37] [38] investigating the role of cognitive functions seen commonly in AD, such as executive, motivational aspects of behavior and emotion processing (for reviews, see [4, 7, 39] ).
Weiland et al. characterized resiliency as the ability for flexible adaptation of psychological control functions appropriate to the respective environmental context [36] . As low resiliency is known to be associated with later alcohol/drug problems and poor working memory performance [36] , they investigated young healthy adolescents with and without a positive family history for alcohol dependence using a 2-back working memory task and observers' ratings based on the California Child Q-Sort as a measurement for resiliency. Resiliency correlated negatively with number of alcohol problems and illicit drugs used but did not differ regarding family history. This might point to the importance of environmental factors apart from genetic influences.
Another study reported that in those with AD who became abstinent, higher functional engagement of brain areas within and outside of the 'classical' working memory network (e.g. rostral/ventrolateral pre-frontal cortex) was associated with executive behavioral control [11] . This may constitute a resilience factor in terms of flexible recruitment of neural resources inside the classical working memory network and further compensatory processes associated with longer duration of abstinence. This is consistent with another fMRI study that also showed functional recruitment of neural working memory network in alcohol dependence [33] , and suggests that such higher activity is productive rather than an impairment.
Drug-associated cue-reactivity has been associated with drug craving (e.g. [16, 40] ) and risk of relapse after detoxification (e.g. [10, 14] ). Two recent prospective studies reported altered cingulate cortex connectivity during individualized imaginary scripts provoking either alcohol-, stress-associated or neutral states in AD [38] . Those patients who showed greater posterior cingulate connectivity during alcohol imagery, or less anterior, mid-cingulate connectivity during neutral trials, showed longer abstinence during the following 90 days and resembled healthy controls. These results emphasize the benefit of functional connectivity analyses in the investigation of neurobiological substrates and relapse risk in AD [38] .
In their prospective study, Beck et al. [10] observed increased neural reactivity during presentation of alcoholassociated cues within mid-brain/subthalamic nucleus as well as ventral striatum in those AD who achieved abstinence compared to relapsers (< 3 months' follow-up) [10] . Further, patients who remained abstinent demonstrated increased functional connectivity between midbrain and amygdala as well as orbitofrontal cortex (OFC) during this alcohol-associated 'cue-reactivity' task compared to those patients who relapsed within 3 months. The authors argued that the increased connectivity between dopaminergic brain areas such as the mid-brain and the amygdala/OFC might help to discriminate and signal aversive aspects of drinking alcohol, and thus may support abstinence.
In the context of reward deficiency, Yau et al. observed reduced ventral striatal response during the anticipation of monetary reward and loss using a monetary incentive delay task (MID) in a group of healthy children of alcohol-dependent (COA) individuals (aged 18-22 years) compared with controls [37] . In addition, in COAs only, activation of ventral striatum was correlated positively with externalizing behavior as well as current and life-time alcohol consumption.
Another important but rarely studied domain in addiction research regarding recovery or resilience is the neural basis of emotion processing. Heitzeg et al. [35] conducted a longitudinal cohort study to investigate externalizing behavioral problems and neural activation patterns during an fMRI task presenting emotional words in adolescents (aged 16-20 years) with a family history of AD who were considered vulnerable (risky drinking behavior) or resilient (no risky drinking behavior). These groups were compared to adolescents without any parental history of AD or risky drinking behavior [35] . In response to emotional stimuli, increased activation in OFC, insula and putamen was n male = 52, n female = 51 FA of AD lower than that of healthy controls.
Relapsing AD showed continued worsening, whereas abstaining AD showed improvement in fiber integrity. FA trajectories of relapsers exhibited faster aging relative to controls, whereas the trajectories of abstainers showed improvement towards normality (Continues) observed in the resilient group. The vulnerable group showed more activation of dorsomedial pre-frontal cortex (PFC) and less activation of ventral striatum and extended amygdala. Increased dorsomedial PFC activation and decreased subcortical activation were linked to greater externalizing behavior [35] . Another study, by Charlet et al. [11] , assessed brain responses during a face-matching task to investigate implicit emotion processing among detoxified AD and healthy controls. Greater activation of anterior cingulate cortex (ACC) during the processing of aversive faces correlated with longer subsequent abstinence and less subsequent binge drinking during the subsequent 6 months. This ACC response may indicate a possible resilience/recovery factor, presumably reflecting successful emotion regulation and error monitoring [12] .
Taken together, findings derived from the fMRI studies indicate potentially important roles of basal ganglia and pre-frontal brain. While two of three studies in COAs point to an increased resilience associated with less task-elicited neural activation within the basal ganglia [36, 37] , those in AD patients showed that greater PFC engagement may underpin resilience against relapse in patients during early abstinence (cf. [10] [11] [12] 33, 38, 41] ).
Resilience and recovery markers detected by studies using PET
Despite the wealth of pre-clinical and clinical evidence about dopaminergic function in addiction [41] [42] [43] , studies focusing on resilience and recovery in alcohol dependence are sparse [16, [44] [45] [46] [47] . Two 11C-raclopride PET studies measured D2/D3 dopamine receptor availability in healthy young adults with either a positive (FHP) or a negative (FHN) family history of AD pre and post an amphetamine challenge. In both, unaffected FHP displayed a higher level of striatal D2 [46] and D2/D3 [44] dopamine receptor availability in striatal regions compared with FHN. Interestingly, while amphetamine resulted in the expected increase in dopamine and positive subjective effects in FHN individuals, this was not found in FHP individuals [44] . Such results support the hypothesis that high D2 receptor availability may serve as a protective biomarker compensating for the higher inherited vulnerability ( [46] , p. 1004). Further, striatal D2 receptor availability in FHP was also linked significantly to pre-frontal glucose metabolism which, in turn, was associated positively with emotional positivity [46] . This suggests that dopaminergic modulation of cognitive control over emotional responses protects against developing alcohol addiction.
In AD, PET studies have demonstrated lower levels of DA receptor availability and DA release compared with healthy controls (e.g. [16, 43] .
Two early studies used PET to assess recovery of brain glucose metabolism during abstinence in AD. One reported a significant increase in brain glucose metabolism predominantly within 16-30 days, especially in frontal brain regions, whereas low metabolism persisted in the basal ganglia [47] . Another study showed that the four patients who remained abstinent compared with two who relapsed showed partial recovery in brain metabolism within frontal cortex areas as well as significant improvement in general cognitive and executive functioning [45] .
In sum, PET studies concentrating on recovery and resilience in alcohol dependence are sparse, but suggest that differences in dopaminergic function may result in vulnerability or resilience depending on the genetic background of an individual. While high D2/D3 receptor availability may serve as protective non-alcoholic FHP, low D2 receptor availability may render individuals more vulnerable to alcohol abuse. Further, similarly to fMRI studies, normalization in metabolism is associated with abstinence.
Resilience and recovery markers detected by sMRI
We found 21 relevant studies investigating changes in brain structure during abstinence ( [21, [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] , cf. Table 1) .
Smaller gray matter (GM) and white matter (WM) volumes have been found throughout the brain and were associated with relapse within 6 months after detoxification [65] . Interestingly, increases in brain volumes were seen even in those patients with moderate alcohol consumption (< 10 g of pure alcohol per day) after detoxification. This indicates beneficial effects of reduced alcohol consumption in AD who are not ready or able to become abstinent [65] . Some brain areas appeared to recover faster, such as the cingulate gyrus in comparison to the fusiform gyrus, which led the authors to propose that recovery in one area triggers recovery in other connected areas.
Along with ventricular volume recovery, significant volume increases in subcortical GM were observed mainly within the first month of abstinence in AD compared with the following 7.5 months of abstinence [53, 62] . Indeed, frontal GM normalized to control level, although total cortical and regional GM volumes (e.g. parietal, temporal, thalamic) remained lower after 7.5 months of abstinence [53] . Similarly, Gazdzinski et al. [54] showed that recovery of brain tissue was six times faster during the first 3 weeks of abstinence than during the subsequent 12 months of abstinence [54] . Brain volume gain was more prominent in heavier drinkers with less tissue at baseline [54] . Partial recovery of cortical thickness was also found after only 2 weeks of sobriety with full normalization seen in medial OFC and rostral ACC. Regeneration of sulci was more pronounced here in all affected brain areas than in gyri [67] . Another study showed significant normalization of hippocampal GM volume within the first 2 weeks of abstinence in AD, especially in those with greater withdrawal severity at baseline [21] .
Other studies have also found smaller tissue volumes associated with greater previous alcohol intake [21, 51] , e.g. in frontal and temporal cortices [51] .
Mon et al. [58] modelled longitudinal brain structure changes mathematically in AD patients, and found that in those with greater GM/WM atrophy at baseline (usually directly after detoxification), greater dynamic neuroplastic changes occurred within the first month of cessation of alcohol intake [58] . Using deformation-based morphometry, two studies by Cardenas et al. reported that 1 week after detoxification patients had smaller frontal and temporal GM and WM volume, but those who remained abstinent regained WM and GM tissue in cortical and subcortical regions after 6-9 months [51] . Apart from structural GM reductions in AD patients relative to controls, subsequent abstainers and relapsers showed different patterns of GM volume loss [50] . In particular, future relapsers showed reduced GM in bilateral OFC in relation to abstainers, which might indicate conservation of GM in this region to benefit recovery in AD patients [50] . In terms of subcortical regions, Deshmukh et al. [52] also discovered regional volume atrophy in caudate, putamen and nucleus accumbens in AD men abstinent for approximately 204 days compared to healthy controls, with greater volume deficits in the nucleus accumbens seen in the more recently abstinent patients [52] .
Interestingly, some studies did not find significant WM differences between AD and controls [53, 67] , although WM volume gain has been detected with abstinence. DTI is probably more sensitive to WM change than structural MRI, as detailed architecture of white matter tissue can be analyzed by visualizing molecule diffusion patterns [48, 55] . For example, a longitudinal study utilizing DTI reported improvement of white matter fiber tract coherence and myelin integrity in the corpus callosum of recently detoxified AD during 1 year of abstinence [48] . Notably, these WM indices in AD no longer differed from controls [48] . However, there was no relationship between these WM changes with normalization of working memory function in the AD [48] . Similarly, normalization of whole brain fiber tract integrity was observed in abstainers with multiple scans during the course of 8 years, while relapsers showed accelerated microstructural damage of the white matter, i.e. faster aging [61] .
Potential modulators
One potential mechanism underlying recovery could be related to genotype, such as has been shown for brainderived neurotropic factor (BDNF Val66Met (rs6265) polymorphism), a promyelination neurotropin which serves as a neurobiological marker of neuronal growth and maintenance [59, 68] [57] .
Structural atrophy and recovery may also vary between genders. Here, a recent study observed that the duration and quantity of heavy drinking was related significantly to WM reductions that differed regionally between male and female AD [63] . Furthermore, stronger positive associations between duration of abstinence and WM volume were seen in women, while men showed this association more so than women after 1 year of sobriety [63] , confirming gender-specific recovery processes [60, 69] . Another gender-driven GM difference indicating heightened vulnerability to brain atrophy in women was observed by Sameti and coworkers [64] : long-term abstinent alcoholdependent women (mean = 6.3 years) displayed smaller nucleus accumbens volumes compared to healthy women and male controls. However, no significant gender effects have also been detected, such as in GM increases and cerebrospinal fluid (CSF) decreases in some brain areas observed within the first 2 weeks of alcohol abstinence [66] .
Comorbid nicotine dependence is also important to consider, because up to 80% of AD smoke [70, 71] and is itself neurotoxic [55, 56] . Evidence is, however, inconsistent. While non-smoking AD revealed faster microstructural recovery (i.e. in frontal, temporal, parietal and occipital lobes) compared with smoking alcohol-dependent patients, faster macrostructural increases in frontal and temporal WM volume were seen in smokers only, with no changes of metabolic concentrations in both groups [55] . Contrary to those WM volume findings, smoking AD were found to show less recovery with increasing age, especially in frontal (and total cortical) GM volume. Moreover, beneficial effects regarding processing speed were associated with the found morphological GM increases, but again in non-smoking AD only [53] . Another study could not support any of these smoking-dependent recovery findings [57] .
Studying neurobiological underpinning of resilience and its predication of problematic alcohol use, a recent European adolescent study by Burt et al., including 1870 teens (average age = 14.56 years), identified elevated GM volumes in pre-frontal areas (BA 11, 10, 6) in resilient adolescents (high competence in academic, social and emotional domains despite experiencing adverse life-time events in the past) compared with other peers, which also correlated negatively with problematic drinking, thus potentially preventing those teens from future AD development by the PFC regulating behavior with protective executive control [49] .
In summary, structural neuroimaging studies demonstrate beneficial plasticity effects throughout the brain of AD during short-, medium-and long-term abstinence, even when patients lower their alcohol consumption to only a moderate level. However, recovery of neuronal tissue (GM versus WM or sulci versus gyri) appears to recover variably across regions (frontal areas first in early abstinence) and at different time rates.
DISCUSSION AND FUTURE AVENUES FOR RESEARCH
Neuroimaging research has been key in shedding light upon possible dysfunctional domains and affected brain regions in AD and their potential of recovery after alcohol cessation (or reduction). In summary, lower dopamine receptor availability as shown in PET studies related to craving in AD patients [16] which, in turn, has been associated with relapse [10, 15] . Moreover, fMRI studies have linked deficient reward and emotion processing to negative treatment outcomes, while structural MRI studies have shown that conserved PFC morphology in particular is linked to resilience and abstinence in AD patients. Altogether, investigations of morphology identified specific factors that influenced these observed brain recovery processes and should be considered in future studies on brain recovery in AD, e.g. genotype-dependent neuronal (re)growth [57, 59] , gender-specific neural recovery effects [52, 60, 63, 64, 66, 69] , additional smoking influences [56, 57, 72] or adolescent alcohol abuse [49] .
Overall, the reviewed research suggests that volumetric brain tissue recovery processes follow non-linear trajectories, suggesting that faster reconstitution of regionally specific brain areas during early abstinence might trigger the recovery of associated regions consecutively. Consistent with these results, additional life-time and current psychiatric diagnoses (such as anxiety disorders, including posttraumatic stress disorder or externalizing disorder) have been identified as critical factors that interfere with morphometric brain recovery in alcohol dependence [64] .
However, in reviewing these studies, one must be aware of some methodological diversity when trying to compare or summarize the existing study findings. Here, in addition to replication studies, meta-analyses that weigh findings by their effect sizes could be employed to preserve false positive findings or small effect-sized results from overestimation. Also, the usage of different self-report instruments (without verification by collateral information) to assess measures of alcohol consumption (e.g. life-time drinking amount, onset and pattern of drinking) should be regarded in light of a potential bias towards socially desirable answers, which might cause underestimation of reported drinking due to embarrassment (e.g. [10] [11] [12] ).
Future studies that aim at systematic investigation of factors that mediate recovery and resilience are the focus of some system-oriented approaches (cf. [73] ). On a functional level, different domains play a crucial role for the development and maintenance of addictive disorders and thus are important factors for recovery, on one hand, and resilience on the other hand: executive functions, including inhibitory control and working memory, reward processing as well as processing of emotional stimuli, are potential targets for diagnosis, prognosis and therapy [10] [11] [12] .
However, until now most imaging studies in this field of research have been cross-sectional, and there is a clear necessity for longitudinal studies into the characterization of disease trajectories, progression rates and markers for recovery and resilience to inform treatment options. Indeed, cohort studies as carried out by the IMAGEN consortium (e.g. [74] ) can shed light on potential future research directions; here, researchers from multiple European countries aim to identify neuronal predictors for developing addictive disorders as well as potential targets for AD prevention approaches. Additional application of machine learning algorithms may further help to generate models of current and future alcohol misuse by incorporating the assessed brain processes and structures, personality as well as cognitive factors, environmental conditions and finally genetic markers [74] . Regarding the identification of intermediate phenotypes of resilience, more studies are clearly needed, as this field of neurobiological research is somewhat unexplored. Here, investigations of individuals with and without heightened genetic or environmental risk for AD are needed to help disentangling resilience markers from vulnerability risk factors. Recent studies also introduced epigenetic mechanisms in AD, adding valuable information about modulating processes to the genotype-phenotype interaction [75] . Those investigations should use appropriate study designs, such as comparisons of (i) adolescent/young adult COAs with versus without AD on their own or (ii) adult AD patients versus adult individuals without AD, but with a positive family history of AD (e.g. first-degree relatives of AD patients) versus healthy individuals without familiar or own AD (as in the recent ongoing prospective cohort study, e:Med SysMed Alcoholism [73] ), respectively. Clearly, findings testing neurobiological traits of vulnerability to AD (cf. [76] [77] [78] ) may give rise to new hypotheses and research questions, but caution is warranted that vulnerability markers are not simply the opposite of resilience. Rather, vulnerability demonstrates conditions and aberrations which exist before AD and may facilitate developing AD but are not only caused by, for example, neurotoxic alcohol effects. Conversely, resilience refers to factors that promote good treatment outcome despite negative effects of longterm alcohol intake on neural structure and function.
Further, future research should not only continue to strengthen knowledge concerning recovery processes and resilience markers (in high-risk groups without alcohol dependence as well as in already affected AD) but should also address whether they can be translated to various drugs of abuse in terms of general markers or can be characterized specifically for different substance classes.
Declaration of interests
None.
